EarliPoint Health Launches Skill Illustrator™ to Help Providers Translate Assessment Data into Actionable Developmental Insights.

Read Release →

Articles

Exploring the science, practice, and people shaping the future of early developmental evaluation.

Subjective vs. Objective Measurement in Autism Care: Why the Field Is Shifting

Autism assessment has always relied on two trusted sources: what a trained clinician observes and what a caregiver reports. Both are rigorous, […]

How to Differentiate Your ABA Practice in a Crowded Market

The ABA field is more crowded than it was five years ago, and the bar for standing out has moved. The phrases […]

When Headphones Aren’t Enough: Helping Children with Autism During Fireworks

For many families, the Fourth of July means backyard barbecues, sparklers, and fireworks. For families of children with autism, it can mean […]

The Six-Month Reassessment Problem: How to Show Progress Objectively

Every six months or so, your practice has to prove that a child is making progress — or risk a reduced authorization, […]

EarliPoint Health Launches Skill Illustrator™ to Help Providers Translate Assessment Data into Actionable Developmental Insights

New feature advances EarliPoint’s vision of delivering objective intelligence across the autism care journey PLYMOUTH, MN — June 16, 2026 — EarliPoint […]

VB-MAPP vs. ABLLS-R vs. AFLS vs. Vineland vs. PEAK: The Complete ABA Assessment Comparison

Ask ten BCBAs which assessment to use and you’ll get ten answers — usually because they’re answering slightly different questions. The VB-MAPP, […]

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder